The potential regulatory mechanism by which the FTH1P3 influences paclitaxel resistance in breast cancer, through its involvement with the miR-206/ABCB1 pathway, provides a new view that could lead to advancements in breast cancer chemotherapy.157. Here, FTH1P3 is linked to breast carcinoma.